Listed

Universal Health Realty Income Trust

UHTNYSECIK 798783Real estateFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$25.0m, Q2 FY2026
Operating income$9.2m, Q2 FY2026
Net income$5.9m, Q2 FY2026
Universal Health Realty Income Trust, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m24.2Revenue, Q3 FY2023, three months to 2023-09-30$24.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figure24.3Revenue, Q4 FY2023, three months to 2023-12-31$24.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure25.1Revenue, Q1 FY2024, three months to 2024-03-31$25.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure24.7Revenue, Q2 FY2024, three months to 2024-06-30$24.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure24.5Revenue, Q3 FY2024, three months to 2024-09-30$24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure24.6Revenue, Q4 FY2024, three months to 2024-12-31$24.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure24.5Revenue, Q1 FY2025, three months to 2025-03-31$24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure24.9Revenue, Q2 FY2025, three months to 2025-06-30$24.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure25.3Revenue, Q3 FY2025, three months to 2025-09-30$25.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure24.5Revenue, Q4 FY2025, three months to 2025-12-31$24.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure24.5Revenue, Q1 FY2026, three months to 2026-03-31$24.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure25.0Revenue, Q2 FY2026, three months to 2026-06-30$25.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Operating income$m8.0Operating income, Q3 FY2023, three months to 2023-09-30$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figure8.2Operating income, Q4 FY2023, three months to 2023-12-31$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure9.5Operating income, Q1 FY2024, three months to 2024-03-31$9.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure9.6Operating income, Q2 FY2024, three months to 2024-06-30$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure8.5Operating income, Q3 FY2024, three months to 2024-09-30$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure9.3Operating income, Q4 FY2024, three months to 2024-12-31$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure9.0Operating income, Q1 FY2025, three months to 2025-03-31$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure8.8Operating income, Q2 FY2025, three months to 2025-06-30$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure8.4Operating income, Q3 FY2025, three months to 2025-09-30$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure8.5Operating income, Q4 FY2025, three months to 2025-12-31$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure9.0Operating income, Q1 FY2026, three months to 2026-03-31$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure9.2Operating income, Q2 FY2026, three months to 2026-06-30$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m3.9Net income, Q3 FY2023, three months to 2023-09-30$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figure3.6Net income, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure5.3Net income, Q1 FY2024, three months to 2024-03-31$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure5.3Net income, Q2 FY2024, three months to 2024-06-30$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure4.0Net income, Q3 FY2024, three months to 2024-09-30$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure4.7Net income, Q4 FY2024, three months to 2024-12-31$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure4.8Net income, Q1 FY2025, three months to 2025-03-31$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure4.5Net income, Q2 FY2025, three months to 2025-06-30$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure4.0Net income, Q3 FY2025, three months to 2025-09-30$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure4.3Net income, Q4 FY2025, three months to 2025-12-31$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure5.0Net income, Q1 FY2026, three months to 2026-03-31$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure5.9Net income, Q2 FY2026, three months to 2026-06-30$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Diluted EPS$ per share0.28Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figurenot reported0.38Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure0.38Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure0.29Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figurenot reported0.34Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure0.32Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure0.29Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figurenot reported0.36Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure0.43Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Basic EPS$ per share0.28Basic EPS, Q3 FY2023, three months to 2023-09-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figurenot reported0.38Basic EPS, Q1 FY2024, three months to 2024-03-31$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure0.38Basic EPS, Q2 FY2024, three months to 2024-06-30$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure0.29Basic EPS, Q3 FY2024, three months to 2024-09-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figurenot reported0.35Basic EPS, Q1 FY2025, three months to 2025-03-31$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure0.33Basic EPS, Q2 FY2025, three months to 2025-06-30$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure0.29Basic EPS, Q3 FY2025, three months to 2025-09-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figurenot reported0.36Basic EPS, Q1 FY2026, three months to 2026-03-31$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure0.43Basic EPS, Q2 FY2026, three months to 2026-06-30$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure

Balance sheet

Cash and equivalents$6.8m, Q2 FY2026
Long-term debt$374.8m, FY2025
Shareholders' equity$143.9m, Q2 FY2026
Universal Health Realty Income Trust, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m8.4Cash and equivalents, Q3 FY2023, at 2023-09-30$8.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0000950170-23-061157.Report this figure8.2Cash and equivalents, FY2023, at 2023-12-31$8.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figure7.7Cash and equivalents, Q1 FY2024, at 2024-03-31$7.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0000950170-24-055718.Report this figure5.6Cash and equivalents, Q2 FY2024, at 2024-06-30$5.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-094044.Report this figure6.4Cash and equivalents, Q3 FY2024, at 2024-09-30$6.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figure7.1Cash and equivalents, FY2024, at 2024-12-31$7.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure7.0Cash and equivalents, Q1 FY2025, at 2025-03-31$7.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure6.6Cash and equivalents, Q2 FY2025, at 2025-06-30$6.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure6.9Cash and equivalents, Q3 FY2025, at 2025-09-30$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure6.7Cash and equivalents, FY2025, at 2025-12-31$6.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure7.1Cash and equivalents, Q1 FY2026, at 2026-03-31$7.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure6.8Cash and equivalents, Q2 FY2026, at 2026-06-30$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Total assets$m608Total assets, Q3 FY2023, at 2023-09-30$607.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061157.Report this figure596Total assets, FY2023, at 2023-12-31$596.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figure596Total assets, Q1 FY2024, at 2024-03-31$596.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055718.Report this figure587Total assets, Q2 FY2024, at 2024-06-30$586.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-094044.Report this figure584Total assets, Q3 FY2024, at 2024-09-30$584.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figure581Total assets, FY2024, at 2024-12-31$580.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure573Total assets, Q1 FY2025, at 2025-03-31$573.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure573Total assets, Q2 FY2025, at 2025-06-30$573.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure568Total assets, Q3 FY2025, at 2025-09-30$568.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure565Total assets, FY2025, at 2025-12-31$564.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure564Total assets, Q1 FY2026, at 2026-03-31$563.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure567Total assets, Q2 FY2026, at 2026-06-30$567.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Total liabilities$m398Total liabilities, Q3 FY2023, at 2023-09-30$397.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061157.Report this figure395Total liabilities, FY2023, at 2023-12-31$395.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figure400Total liabilities, Q1 FY2024, at 2024-03-31$399.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055718.Report this figure396Total liabilities, Q2 FY2024, at 2024-06-30$395.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-094044.Report this figure403Total liabilities, Q3 FY2024, at 2024-09-30$402.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figure401Total liabilities, FY2024, at 2024-12-31$401.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure401Total liabilities, Q1 FY2025, at 2025-03-31$401.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure408Total liabilities, Q2 FY2025, at 2025-06-30$407.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure409Total liabilities, Q3 FY2025, at 2025-09-30$409.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure413Total liabilities, FY2025, at 2025-12-31$412.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure416Total liabilities, Q1 FY2026, at 2026-03-31$416.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure423Total liabilities, Q2 FY2026, at 2026-06-30$423.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure
Long-term debt$mnot reported360Long-term debt, FY2023, at 2023-12-31$359.7m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-02-27, accession 0000950170-24-021191.Report this figurenot reportednot reportednot reported368Long-term debt, FY2024, at 2024-12-31$368.4m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figurenot reportednot reportednot reported375Long-term debt, FY2025, at 2025-12-31$374.8m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figurenot reportednot reported
Shareholders' equity$m210Shareholders' equity, Q3 FY2023, at 2023-09-30$210.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-08, accession 0000950170-23-061157.Report this figure201Shareholders' equity, FY2023, at 2023-12-31$200.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-26, accession 0000950170-25-027861.Report this figure196Shareholders' equity, Q1 FY2024, at 2024-03-31$196.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-08, accession 0000950170-24-055718.Report this figure191Shareholders' equity, Q2 FY2024, at 2024-06-30$190.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-08, accession 0000950170-24-094044.Report this figure182Shareholders' equity, Q3 FY2024, at 2024-09-30$181.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figure180Shareholders' equity, FY2024, at 2024-12-31$179.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001193125-26-071594.Report this figure172Shareholders' equity, Q1 FY2025, at 2025-03-31$172.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure165Shareholders' equity, Q2 FY2025, at 2025-06-30$165.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure159Shareholders' equity, Q3 FY2025, at 2025-09-30$158.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure152Shareholders' equity, FY2025, at 2025-12-31$152.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure148Shareholders' equity, Q1 FY2026, at 2026-03-31$147.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure144Shareholders' equity, Q2 FY2026, at 2026-06-30$143.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure

Cash flow

Operating cash flow$12.4m, Q2 FY2026
Capital expenditure$22.0k, Q4 FY2023
Universal Health Realty Income Trust, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m10.2Operating cash flow, Q3 FY2023, three months to 2023-09-30$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0000950170-24-124121. Derived: 9-month figure less the 6-month figure.Report this figure10.5Operating cash flow, Q4 FY2023, three months to 2023-12-31$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure11.7Operating cash flow, Q1 FY2024, three months to 2024-03-31$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure12.1Operating cash flow, Q2 FY2024, three months to 2024-06-30$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001193125-25-177000. Derived: 6-month figure less the 3-month figure.Report this figure9.9Operating cash flow, Q3 FY2024, three months to 2024-09-30$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272382. Derived: 9-month figure less the 6-month figure.Report this figure13.2Operating cash flow, Q4 FY2024, three months to 2024-12-31$13.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure11.6Operating cash flow, Q1 FY2025, three months to 2025-03-31$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure13.7Operating cash flow, Q2 FY2025, three months to 2025-06-30$13.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340281. Derived: 6-month figure less the 3-month figure.Report this figure10.2Operating cash flow, Q3 FY2025, three months to 2025-09-30$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272382. Derived: 9-month figure less the 6-month figure.Report this figure13.6Operating cash flow, Q4 FY2025, three months to 2025-12-31$13.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure12.0Operating cash flow, Q1 FY2026, three months to 2026-03-31$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure12.4Operating cash flow, Q2 FY2026, three months to 2026-06-30$12.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340281. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reported0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Dividends paid$m9.9Dividends paid, Q3 FY2023, three months to 2023-09-30$9.9m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figure10.0Dividends paid, Q4 FY2023, three months to 2023-12-31$10.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure10.0Dividends paid, Q1 FY2024, three months to 2024-03-31$10.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure10.2Dividends paid, Q2 FY2024, three months to 2024-06-30$10.2m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure10.1Dividends paid, Q3 FY2024, three months to 2024-09-30$10.1m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure10.2Dividends paid, Q4 FY2024, three months to 2024-12-31$10.2m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure10.2Dividends paid, Q1 FY2025, three months to 2025-03-31$10.2m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure10.3Dividends paid, Q2 FY2025, three months to 2025-06-30$10.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure10.3Dividends paid, Q3 FY2025, three months to 2025-09-30$10.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure10.3Dividends paid, Q4 FY2025, three months to 2025-12-31$10.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-25, accession 0001193125-26-071594. Derived: 12-month figure less the 9-month figure.Report this figure10.3Dividends paid, Q1 FY2026, three months to 2026-03-31$10.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure10.5Dividends paid, Q2 FY2026, three months to 2026-06-30$10.5m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure

Shares

Diluted shares (weighted)13.88m, Q2 FY2026
Universal Health Realty Income Trust, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares13.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3013,801,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061157.Report this figure13.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3113,803,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055718.Report this figure13.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3013,809,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-094044.Report this figure13.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3013,822,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0000950170-24-124121.Report this figure13.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3113,824,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-067009.Report this figure13.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3013,832,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001193125-25-177000.Report this figure13.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3013,849,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure13.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3113,851,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure13.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3013,856,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure13.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3013,874,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272382.Report this figure13.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3113,875,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211984.Report this figure13.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3013,881,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure

Shares outstanding: 13.90mShares outstanding, period not labelled, at 2026-07-3113,898,684 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-07, accession 0001193125-26-340281.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. Listed shows no prices and gives no investment advice.